Gel filtration has shown that there are considerable differences between the metal complexes of bleomycin A2 and B2 with indium, cobalt or copper.
The bleomycins are a closely related group of water-soluble glycopeptides (each differing in an amine side chain), and are obtained from the culture of a strain of Streptomyces verticillus. Since their discovery by UMEZAWA et a11.2> they have been increasingly used for the chemotherapy of some types of tumours') and, when labelled with a radionuclide, as tumour imaging compounds"".
Originally the copper chelate produced by the organism was used for chemotherapy, however, indications were that this form was more toxic and irritating than the copper-free preparation which is now used8). Besides the ability to bind copper, bleomycin has the capacity to bind various other metals which has been extensively investigated for tumour imaging by using a complex with metal radionuclides4-6). Any differences between the different bleomycin-metal complexes might be expected to effect their biological behaviour. There are indications that the "'In and 67Co complexes at present widely used for tumour imaging exhibit greater differences than the known interactions of the individual metals within the body would suggests). Furthermore, a number of workers have shown that bleomycins cause effects (such as scission of DNA and a reduction in its melting temperature) that are enhanced by agents containing sulfhydryl groups or by hydrogen peroxide, but are inhibited by metal ions such as copper and cobalt, and by EDTA.IO.11) This indicates that metal-bleomycin interactions may have important effects on the attack and inhibition processes.
The chemical formula of bleomycin has been established" but the conformation has not yet been elucidated. Gel permeation chromatography has been used to study conformational changes such as those that occur when metals bind transferrin"> and when organic reagents react with albumin"'. This paper reports some results of experiments designed to observe the effect on the molecule of binding metals using bleomycin (BLM) as supplied for clinical use (which is a mixture) and separated samples of BLM-A, and BLM-B, together with radionuclides of indium, cobalt, and copper.
Methods

Preparation of compounds
Freeze-dried bleomycin sulphate in 15 mg ampoules for injection was kindly supplied by Lundbeck Ltd., Luton, Bedfordshire, England. They also supplied a quantity of separated BLM-A2, batch VOL. XXIX NO. 10 THE JOURNAL OF ANTIBIOTICS CM-25 and BLM-B, batch F-4. All samples were supplied copper-free. The radionuclides used were carrier-free and were made in this Unit "'In"), "Cu (unpublished work), or supplied by the Radiochemical Centre, Amersham, England(111In, 67Co).
The indium and cobalt bleomycin complexes were made by adding the radionuclides as their chlorides in 0.2 mi of 0.02 M HCI to a solution of 1 mg/ml bleomycin in 0.9 % NaCI and after 5 minutes at room temperature, adjusting the pH to 7.4 with 0.1 M NaHCO2 solution.
The copper bleomycin complexes were made by adding"Cu in 0.2 ml of 0.9 o NaCI to a solution of I mg/ml bleomycin in 0.9 NaCI at room temperature.
2. Thin-layer chromatography This was performed using precoated plates of silica gel without binder 0.25 mm thick (MachereyNagel). Samples of approximately 10 /cl were spotted onto the plates 1 cm from the bottom and dried. The plates were developed in a solvent saturated atmosphere with 10% aqueous ammonium acetatemethanol (1 : 1, v/v) until the solvent front had travelled 15 cm from the origin.
After air drying the plates were assayed for radioactivity with a scanning system utilising a 25 x 38 mm sodium iodide crystal linked to a 1000 channel analyser in multiscaler mode. After obtaining quantitative data in this way autoradiographs of the plates were made using Ilford Red Seal X-ray film. This gave higher resolution pictures of the radioactive spots on the plate than the scanning system. With the amounts used it was not always possible to visualise the bleomycin spots chemically, however, at all times when labelling occurred the Rf value of the radioactive spots coincided with the known values of stable bleomycin.
3. Gel Permeation Chromatography This was performed using a BioRad glass column of 7 mm inside diameter filled to 25 cm with G-15 Sephadex (Pharmacia), pre-swollen in the eluant (0.9% NaCI in water). A polythene sinter was placed on the top of the column bed to prevent disturbance of the surface. The eluant head was maintained at 50 cm using a Mariotte flask and gave a flow rate of 0.1 ml/min.
The column eluate was passed through a 2-mm path length, vertical flowthrough optical cell, which was illuminated with UV light of 254 nm wavelength. The absorbance was measured with an ISCO UA-4 ultraviolet absorbance monitor; 0.5-m1 fractions were collected using a Gilson MTDC fraction collector coupled to the UA-4 so that fractions were marked on the absorbance trace. Small bore PTFE tubing was used throughout and gave a dead volume between the centre of the flow-through cell and the fraction collector of 0.1 ml. Radioactivity was measured in each tube (after all the samples had been collected) with a well-type scintillation counter. The sample volume was 0.1-0.4 ml.
Results
The bleomycin used clinically is a mixture which consists of approximately 65% BLM-A2 (Mol.
wt. 1,385) and 30% BLM-B2 (Mol. wt. 1,395). There are some other components, but these do not total more than a few percent collectively. The structure of the two most abundant bleomycins is shown in Fig. 1 ., the difference between BLM-A2 and BLM-B2 is seen to reside in the amine side chain. The analysis by thin-layer chromatography showed that samples used for gel permeation experiments contained >98% of the radionuclide bound to bleomycins.
The results of the gel permeation experiments are reproduced in Figs. 3 and 4 and are shown as continuous UV absorbance traces with the corresponding radioactivities per fraction collected superimposed. All the absorbance traces were reproducible as regards peak-position over three or more runs, both with samples from the same batch of labelled BLM, and also from batch to batch. There were some minor differences in peak shape that were due to differences in sample application and size. 
Discussion
Under optimum conditions the passage of different compounds through a dextran gel such as Sephadex G-15 depends upon the physical size of the molecules. If all the molecules are approximately the same shape, measurement of the elution volumes can lead to a figure for the molecular weight for an unknown compound after suitable calibration procedures").
The difference between the molecular weight of BLM-A2 and BLM-B2 is < 1 % and cannot be resolved by the system used. Any differences in elution volume, therefore, must either be a result of changes in size (i.e. STOKES radius of the molecule) , or some other means of selectivity such as ion-exchange. It is known that positively charged species may be retarded on dextran gels due to the presence of a small number of -OH groups on the gels, however, this can be minimised if the ionic strength of the eluant is maintained above 0.0216). Experiments have shown that in this case the use of isotonic saline (0.9% NaCI, ionic strength 0.15) prevents any obvious ion-exchange effects.
(1) Metal-free Bleomycins Fig. 3 . shows the elution curves for metal-free BLM-A2, BLM-B2 and BLM mixture. Because of the smaller elution volume BLM-A2 apears to be bigger than BLM-B2. The curve for the mixture is what one would expect from a composite of the curves for BLM-A2 and BLM-B2. Curves of solutions containing equal quantities by weight of BLM-A2 and BLM-B2 (not shown) exhibit two peaks with the expected elution volumes.
Clearly there is an appreciable difference in elution of the two bleomycins and since the only The terminal guanidine group of B2 would be protonated at a neutral pH so that there is no charge difference between BLM-A2 and BLM-B2. It is possible that a combination of charge and the shorter length of the chain causes the BLM-A2 amine moiety to project more into the solvent away from the bulk of the molecule, thus increasing its STOKES radius. This is greater for BLM-B, than for BLM-A, but still smaller than that for indium.
The curves for copper in Fig. 4 . show that there is no detectable change of BLM-A, or BLM-B, when copper is bound.
In all cases the elution profiles for the metal complexes of the bleomycin mixture expected from consideration of the separated bleomycin-metal complexes have been obtained experimentally.
The possible differences in charge between the Ina+-BLM complexes and the Met bleomycin complexes does not appear to be operative in this instance because of the lack of similarity between cobalt and copper complexes and the obvious progression in elution shown by copper, cobalt and indium bleomycins. The elution volume of the "In in the "'In-B2 preparation suggests that the STOKES radius of the Fig. 4 . Gel filtration on G-15 of metal complexes of bleomycin A2 and bleomycin B2 -absorbance , ---------radioactivity.
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THE JOURNAL OF ANTIBIOTICS OCT. 1976 complex is approaching that of hydrated metal ions. Dissociation of the complex has been ruled out in this case because analysis of the fractions collected has shown all the indium to be present bound to BLM B2, and because carrier-free indium is strongly retarded on the Sephadex. It is possible that there are some weak effects peculiar to InBLM-B2 that are retarding these complexes thus enhancing the apparent natural progression (from copper to indium) of increasing elution volume. Indium prefers an octahedral configuration, cobalt favours octahedral or tetrahedral configurations depending upon the ligand, and copper favours square planar or distorted tetrahedral configurations. It is reasonable to assume that the site of co-ordination of different metals would be similar for different co-ordination numbers-i.e. some of the ligand atoms would be the same in all cases.
The molar ratio for the indium BLM-B2 complex has been found to be 1 : 1 as it is for the copper complex and one can infer that this is the molar ratio for all metals specifically bound to the bleomycin molecule. The gel filtration data obtained indicate that polymerisation has not occurred.
The changes detected in the elution of the different BLM-metal complexes might be the result of two factors. The first is the different co-ordinatic numbers preferred by the individual metals. The second is the number of co-ordination positions occupied by ligands arising from the bleomycin molecule. Both would produce changes in the conformation of the bleomycin molecule.
Both copper and cobalt bind to bleomycin instantaneously at 20'C in 0.9% NaCI at neutral pH. Indium requires 20 minutes at 80°C before 100%. labelling occurs under these conditions.
Binding is complete within one minute at pH 2.5 and becomes slower at a lower pH.
Bleomycins have been found to have pKa' values of 2.9, 4.7 and 7.3 which have been assigned to the 4-aminopyrimidine, imidazole and /3-aminoalanine groups respectively").
If metal binding involves any of these sites as has been suggested for the most basic group") proton competition would occur. It follows that if protonation of metal binding sites only is considered, metal binding should be improved at a high pH where protonation is minimised. The pH of the solution does not have any detectable effect on the binding of copper or cobalt to bleomycin within the range investigated.
At pH 2.5 where protonation of the /J-aminoalanine and imidazole groups would be essentially complete and where the 4-amino pyrimidine group would be 30 % protonated, incorporation of indium is rapid. Thus, these changes in the rate of incorporation of indium into bleomycin cannot be attributed to protonation of the metal binding sites.
Although indium is known to precipitate above pH 3.511) labelling still occurs, at least upto pH 7.5. Any carrier-free hydrolysed indium species present do not prevent eventual binding to bleomycin. Olation would not be expected to occur as the indium is "carrier free". Trace metal impurities such as iron which may be capable of forming polynuclear species with the indium, but which do not bind to the bleomycin themselves, do not effect binding of indium to bleomycin under the conditions used.
The aqueous chemistry of indium has been investigated'8> and it has been shown that with a large excess of chloride present the [In(H2O),Cl]21 species is the predominant one. One can deduce, therefore, that the changes of binding rate of indium to bleomycin induced by changes in pH cannot be the result of changes in the indium species present.
It is possible that changes in pH would effect the conformation of the bleomycin molecule. As copper and cobalt bind immediately to bleomycin at a neutral pH one can assume that the conformation of the bleomycin is already adequate for these metals to bind.
The increase in temperature at neutral pH, or the lowering of pH required for indium to bind rapidly could be due to a necessary change in conformation of the bleomycin which results in an increase in STOKES radius. If this is so, it would be correct to attribute the differences between cobalt and copper to be due to difference in co-ordination type -tetrahedral v/s square planar, (both having co-ordination numbers of four). Furthermore, one may explain the difference between indium and the other two metals to be primarily due to co-ordination number (six), but also influenced by co-ordination type.
As yet the exact binding site of metals has not been elucidated. The d-d spectrum of Cu BLM shows strong absorption at 595 nmt which is characteristic of copper bound to four nitrogen atoms. The molar extinction ~ 300 is in agreement with other values obtained when copper is chelated to a large molecule. There is no spectral evidence of copper-sulphur bonding. VOL. XXIX NO. 10 THE JOURNAL OF ANTIBIOTICS UMEZAWA12) has suggested that the a-amino group of the /3-aminoalanine moiety is a site of copper binding because of the disappearance of the pKa' of this group when copper is bound. The carboxamide group of this area of the molecule appears to be important in the attack of DNA by bleomycins as an inactivating enzyme has been shown to attack this group19 . Due to the close proximity of a proposed metal binding group and a group that is necessary for DNA attack it is feasible that the way in which copper prevents the attack of DNA by bleomycin is to alter the conformation of the bleomycin molecule and to introduce steric hindrance between the reacting groups.
The 3-O-carbamoyl group is known to undergo rearrangement to the 2-position"). This rearrangement is prevented by copper chelation but each isomer can still bind copper. Thus, this group is indicated as providing a ligand atom. There are no other strong indications for ligand providing groups apart from the possible involvement of the amine side chains with some metals.
The strength of the bond between the metal and the bleomycin is quite high. It has been shown that bleomycin will remove 74 % of cobalt from a CoEDTA complex over a period of 72 hours21), but the reverse reaction does not occur.
I have found that copper in ten-fold excess with respect to bleomycin rapidly substitutes "'In in "In-BLM and that cobalt removes "'In at a slower rate2l> . The indium complex is thus not stable in the presence of Cu2+ or Cot+. It follows that if "'In-BLM encounters available copper in vivo it is likely that the copper complex will be formed and the "'In released. Metals found to inhibit attack of DNA by bleomycins react with sulfhydryl groups. Work is at present in progress to determine the interactions between Cult, Cot+, Zn2+, 2-mercaptoethanol, and bleomycin to try and elucidate mechanisms for the changes in attack of DNA by bleomycins. Preliminary results suggest that when there is a large excess of 2-mercaptoethanol compared to Cu2+, Co2+ or Zn2+ the competition between 2-mercaptoethanol and the bleomycin for the metals favours the 2-mercaptoethanol.
However, when there is an increased amount of these metals present the bleomycin is all complex with them so that inhibition of attack of DNA occurs.
Conclusions
As yet, no crystallographic data on the complete bleomycin-metal complex system have been published. The results of experiments reported in this paper show that there are differences in the Gel Permeation elution characteristics of BLM-metal complexes which show some progression from copper through cobalt to indium. This is thought to be mainly due to differences in STOKES radius caused by the different co-ordination characteristics of the metals, however, the elution characteristics of the "In-B2 complex suggests that there may be in addition other selectivity effects. These effects may be operative in vivo and could contribute to the differences in character of the various BLM-metal complexes which are thought to alter their in vivo chemistry and thus their usefulness in medicine.
